HLS Therapeutics Inc (HLS.TO)
3.66
+0.06
(+1.67%)
CAD |
TSX |
Sep 27, 16:00
HLS Therapeutics Total Liabilities (Quarterly): 148.72M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 148.72M |
| March 31, 2024 | 147.15M |
| December 31, 2023 | 147.68M |
| September 30, 2023 | 154.12M |
| June 30, 2023 | 152.88M |
| March 31, 2023 | 155.86M |
| December 31, 2022 | 157.82M |
| September 30, 2022 | 162.57M |
| June 30, 2022 | 157.47M |
| March 31, 2022 | 139.17M |
| December 31, 2021 | 146.78M |
| September 30, 2021 | 152.04M |
| June 30, 2021 | 156.53M |
| March 31, 2021 | 163.15M |
| December 31, 2020 | 171.70M |
| September 30, 2020 | 183.56M |
| June 30, 2020 | 168.33M |
| March 31, 2020 | 194.13M |
| December 31, 2019 | 184.77M |
| September 30, 2019 | 178.43M |
| June 30, 2019 | 185.48M |
| March 31, 2019 | 190.68M |
| December 31, 2018 | 201.52M |
| September 30, 2018 | 201.39M |
| June 30, 2018 | 243.27M |
| Date | Value |
|---|---|
| March 31, 2018 | 253.18M |
| December 31, 2017 | 256.76M |
| September 30, 2017 | 0.9464M |
| June 30, 2017 | 0.7223M |
| March 31, 2017 | 0.6648M |
| December 31, 2016 | 0.744M |
| September 30, 2016 | 0.7003M |
| June 30, 2016 | 0.6068M |
| March 31, 2016 | 0.5268M |
| December 31, 2015 | 0.7937M |
| September 30, 2015 | 0.8476M |
| June 30, 2015 | 1.142M |
| March 31, 2015 | 4.765M |
| December 31, 2014 | 15.57M |
| September 30, 2014 | 21.20M |
| June 30, 2014 | 18.99M |
| March 31, 2014 | 14.72M |
| December 31, 2013 | 15.21M |
| September 30, 2013 | 11.37M |
| June 30, 2013 | 10.70M |
| March 31, 2013 | 6.980M |
| December 31, 2012 | 8.639M |
| September 30, 2012 | 18.72M |
| June 30, 2012 | 14.98M |
| March 31, 2012 | 10.84M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
139.17M
Minimum
Mar 2022
194.13M
Maximum
Mar 2020
161.14M
Average
157.00M
Median
Total Liabilities (Quarterly) Benchmarks
| DRI Healthcare Trust | 348.80M |
| Biocure Technology Inc | 0.44M |
| Core One Labs Inc | 1.759M |
| Nova Mentis Life Science Corp | 1.072M |
| Nanosphere Health Sciences Inc | 2.276M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 261.96M |
| Shareholders Equity (Quarterly) | 113.24M |
| Debt to Equity Ratio | 0.9968 |
| Current Ratio | 2.024 |
| Net Debt Paydown Yield | 2.76% |